Trending Now
Business
Allergan – $2 Billion Share Buybacks Confirm Growth Is Dead
Monday morning Allergan (AGN) announced it had authorized a $2 billion share repurchase program and reaffirmed its Q3 2017 revenue projections:
Allergan plc (AGN) today...
Valeant: Where Is The Growth?
Valeant (VRX) reported Q3 earnings last week. The company delivered revenue of $2.22 billion and adjusted net income of $367 million. Valeant beat on...
Lifestyle today
Entertainment
State AG Voices Enthusiasm For Opioid Settlement
The number of accidental deaths related to opioids and the number of people addicted to them have been on the rise. Some believe such...
New York Senators Lobby Cuomo For Access To Opioid Settlement Funds
The opioid crisis has dominated the public consciousness for several months. We all knew thousands and of lives and communities across the country had...
Why Impact Biomedicines Could Be Celgene’s Next Embarrassment
Celgene (CELG) has been reeling as of late. It has brandished an image as having a strong R&D pipeline and an ability to acquire...
McKesson Concurs With Federal Judge; Demands Global Opioid Settlement
The opioid epidemic continues to dominate the national consciousness. Â The number of accidental deaths related to opioids and the number of people addicted to...
Will Liver Risk Stymie Allergan’s Fibroid Drug?
Friday European Union ("EU") regulators began an investigation of Esmya (ulipristal acetate) which is used to treat symptons of uterine fibroid:
European Union (EU) regulators...
Teva – Potential Coronavirus Treatment Offers More Upside
The opioid epidemic continues to dominate the public discourse. The question remains, "What can be done about it?" The number of accidental deaths related...
Micron: Is The Catbird Seat Heating Up?
Micron (MU) reported Q2 revenue of $7.35 billion and eps of $2.82. The company beat on revenue by $70 million and beat on eps...
General Electric: Was That A Run On The Bank?
Earlier this month, General Electric (GE) abandoned its use of commercial paper:
Once the largest borrower in the market, GE Capital is abandoning its use...






















































































































